Sara Deakin

1.6k total citations
20 papers, 1.3k citations indexed

About

Sara Deakin is a scholar working on Clinical Biochemistry, Plant Science and Pharmacology. According to data from OpenAlex, Sara Deakin has authored 20 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Clinical Biochemistry, 10 papers in Plant Science and 8 papers in Pharmacology. Recurrent topics in Sara Deakin's work include Paraoxonase enzyme and polymorphisms (18 papers), Cynara cardunculus studies (10 papers) and Hibiscus Plant Research Studies (8 papers). Sara Deakin is often cited by papers focused on Paraoxonase enzyme and polymorphisms (18 papers), Cynara cardunculus studies (10 papers) and Hibiscus Plant Research Studies (8 papers). Sara Deakin collaborates with scholars based in Switzerland, Australia and United States. Sara Deakin's co-authors include Richard W. James, Ilia Leviev, Guido Franceschini, Laura Calabresi, Monica Gomaraschi, Marie‐Claude Brulhart‐Meynet, Marie‐Luce Bochaton‐Piallat, Sureerut Porntadavity, Marja‐Riitta Taskinen and Sherri Bisset and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Clinical Endocrinology & Metabolism and Biochemical Journal.

In The Last Decade

Sara Deakin

20 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara Deakin Switzerland 16 1.1k 550 364 269 200 20 1.3k
M. Mackness United Kingdom 15 573 0.5× 285 0.5× 197 0.5× 152 0.6× 91 0.5× 17 1.3k
P. Stetson United States 6 251 0.2× 122 0.2× 72 0.2× 103 0.4× 64 0.3× 8 462
Juan J. Vila Spain 4 146 0.1× 94 0.2× 56 0.2× 47 0.2× 23 0.1× 5 614
Maribel Covas Spain 6 148 0.1× 97 0.2× 54 0.1× 48 0.2× 25 0.1× 6 392
Khalid Z. Alshali Saudi Arabia 18 100 0.1× 159 0.3× 94 0.3× 37 0.1× 27 0.1× 42 1.3k
Ch. Heierli Switzerland 7 58 0.1× 105 0.2× 78 0.2× 32 0.1× 96 0.5× 14 840
G Pisani Argentina 16 36 0.0× 94 0.2× 37 0.1× 37 0.1× 85 0.4× 41 749
Harley Liker United States 12 59 0.1× 377 0.7× 55 0.2× 7 0.0× 90 0.5× 15 1.3k
Surat Komindr Thailand 20 35 0.0× 93 0.2× 45 0.1× 31 0.1× 67 0.3× 53 1.1k
S N Chugh India 16 39 0.0× 376 0.7× 19 0.1× 24 0.1× 215 1.1× 23 743

Countries citing papers authored by Sara Deakin

Since Specialization
Citations

This map shows the geographic impact of Sara Deakin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Deakin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Deakin more than expected).

Fields of papers citing papers by Sara Deakin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Deakin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Deakin. The network helps show where Sara Deakin may publish in the future.

Co-authorship network of co-authors of Sara Deakin

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Deakin. A scholar is included among the top collaborators of Sara Deakin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Deakin. Sara Deakin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deakin, Sara, et al.. (2014). Modulating reconstituted high density lipoprotein functionality to target the Pseudomonas aeruginosa quorum sensing system. Life Sciences. 112(1-2). 68–73. 1 indexed citations
2.
Deakin, Sara, et al.. (2010). HDL-associated paraoxonase-1 can redistribute to cell membranes and influence sensitivity to oxidative stress. Free Radical Biology and Medicine. 50(1). 102–109. 89 indexed citations
3.
Brulhart‐Meynet, Marie‐Claude, Sara Deakin, Antonino Sgroi, Léo H. Bühler, & Richard W. James. (2010). Expression of the hepatic Niemann–Pick C1 like 1 protein gene is sensitive to rosuvastatin treatment of primary human hepatocytes. Pharmacogenetics and Genomics. 20(7). 455–458. 3 indexed citations
4.
James, Richard W., Marie‐Claude Brulhart‐Meynet, Anurag Kumar Singh, et al.. (2010). The Scavenger Receptor Class B, Type I Is a Primary Determinant of Paraoxonase-1 Association With High-Density Lipoproteins. Arteriosclerosis Thrombosis and Vascular Biology. 30(11). 2121–2127. 21 indexed citations
5.
James, Richard W. & Sara Deakin. (2009). The Contribution of High Density Lipoprotein Apolipoproteins and Derivatives to Serum Paraoxonase-1 Activity and Function. Advances in experimental medicine and biology. 660. 173–181. 25 indexed citations
6.
Deakin, Sara, et al.. (2009). Effect of atorvastatin on paraoxonase1 (PON1) and oxidative status. Pharmacological Reports. 61(5). 892–898. 52 indexed citations
7.
Deakin, Sara, et al.. (2008). HDL subfraction distribution of paraoxonase-1 and its relevance to enzyme activity and resistance to oxidative stress. Journal of Lipid Research. 49(6). 1246–1253. 32 indexed citations
8.
Markham, Wolfgang, Paul Aveyard, Sherri Bisset, et al.. (2007). Value‐added education and smoking uptake in schools: a cohort study. Addiction. 103(1). 155–161. 36 indexed citations
9.
Deakin, Sara, et al.. (2007). Pharmacogenetic interaction between paraoxonase-1 gene promoter polymorphism C-107T and statin. Pharmacogenetics and Genomics. 17(6). 451–457. 22 indexed citations
10.
Deakin, Sara, et al.. (2007). HDL Oxidation Compromises its Influence on Paraoxonase-1 Secretion and its Capacity to Modulate Enzyme Activity. Arteriosclerosis Thrombosis and Vascular Biology. 27(5). 1146–1152. 49 indexed citations
11.
James, Richard W. & Sara Deakin. (2004). The importance of high-density lipoproteins for paraoxonase-1 secretion, stability, and activity. Free Radical Biology and Medicine. 37(12). 1986–1994. 154 indexed citations
12.
Deakin, Sara, et al.. (2004). Very low density lipoproteins provide a vector for secretion of paraoxonase-1 from cells. Atherosclerosis. 179(1). 17–25. 56 indexed citations
13.
Deakin, Sara, et al.. (2004). Genetic and environmental factors modulating serum concentrations and activities of the antioxidant enzyme paraoxonase-1. Clinical Science. 107(5). 435–447. 222 indexed citations
14.
Deakin, Sara, et al.. (2003). Simvastatin Modulates Expression of the PON1 Gene and Increases Serum Paraoxonase. Arteriosclerosis Thrombosis and Vascular Biology. 23(11). 2083–2089. 131 indexed citations
15.
Deakin, Sara, Ilia Leviev, Marie‐Claude Brulhart‐Meynet, & Richard W. James. (2003). Paraoxonase-1 promoter haplotypes and serum paraoxonase: a predominant role for polymorphic position −107, implicating the Sp1 transcription factor. Biochemical Journal. 372(2). 643–649. 104 indexed citations
16.
Deakin, Sara, et al.. (2002). Paraoxonase-1 L55M Polymorphism Is Associated with an Abnormal Oral Glucose Tolerance Test and Differentiates High Risk Coronary Disease Families. The Journal of Clinical Endocrinology & Metabolism. 87(3). 1268–1273. 28 indexed citations
17.
Deakin, Sara, Ilia Leviev, Monica Gomaraschi, et al.. (2002). Enzymatically Active Paraoxonase-1 Is Located at the External Membrane of Producing Cells and Released by a High Affinity, Saturable, Desorption Mechanism. Journal of Biological Chemistry. 277(6). 4301–4308. 204 indexed citations
18.
Deakin, Sara. (2002). Paraoxonase-1 L55M Polymorphism Is Associated with an Abnormal Oral Glucose Tolerance Test and Differentiates High Risk Coronary Disease Families. The Journal of Clinical Endocrinology & Metabolism. 87(3). 1268–1273. 5 indexed citations
19.
Deakin, Sara, Ilia Leviev, Laura Calabresi, Guido Franceschini, & Richard W. James. (2001). Secretion of human paraoxonase 1: evidence for an HDL acceptor mechanism. Atherosclerosis Supplements. 2(2). 74–74. 1 indexed citations
20.
Leviev, Ilia, Sara Deakin, & Richard W. James. (2001). Decreased stability of the M54 isoform of paraoxonase as a contributory factor to variations in human serum paraoxonase concentrations. Journal of Lipid Research. 42(4). 528–535. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Mackness Breakdown of academic impact, for papers by P. Stetson Breakdown of academic impact, for papers by Juan J. Vila Breakdown of academic impact, for papers by Maribel Covas Breakdown of academic impact, for papers by Khalid Z. Alshali Breakdown of academic impact, for papers by Ch. Heierli Breakdown of academic impact, for papers by G Pisani Breakdown of academic impact, for papers by Harley Liker Breakdown of academic impact, for papers by Surat Komindr Breakdown of academic impact, for papers by S N Chugh
Rankless by CCL
2026